• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年冠状病毒病大流行期间肌萎缩侧索硬化症患者的分诊:D50模型的应用

Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model.

作者信息

Steinbach Robert, Prell Tino, Gaur Nayana, Stubendorff Beatrice, Roediger Annekathrin, Ilse Benjamin, Witte Otto W, Grosskreutz Julian

机构信息

Hans Berger Department of Neurology, Jena University Hospital, 07747 Jena, Germany.

Center for Healthy Ageing, Jena University Hospital, 07747 Jena, Germany.

出版信息

J Clin Med. 2020 Sep 5;9(9):2873. doi: 10.3390/jcm9092873.

DOI:10.3390/jcm9092873
PMID:32899481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7565659/
Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease, the management of which requires the continuous provision of multidisciplinary therapies. Owing to the novel coronavirus disease (COVID-19) pandemic, regular contact with ALS patients at our center was severely restricted and patient care was at risk by delay of supportive therapies. We established a triage system based on the D50 disease progression model and were thus able to identify a prospective cohort with high disease aggressiveness (D50 < 30). Thirty-seven patients with highly aggressive disease were actively offered follow-up, either via telephone or on-site, depending on their disease-specific needs and abilities. We describe here the procedures, obstacles, and results of these prescient efforts during the restrictions caused by COVID-19 in the period between March and June 2020. In conclusion, four patients with highly aggressive disease were initiated with non-invasive ventilation and two received a gastrostomy. We could show that a comparable amount of advanced care was induced in a retrospective cohort within a similar time period one year prior to the COVID-19 outbreak. Our workflow to identify high-risk patients via D50 model metrics can be easily implemented and integrated within existing centers. It helped to maintain a high quality of advanced care planning for our ALS patients.

摘要

肌萎缩侧索硬化症(ALS)是一种进行性神经肌肉疾病,其治疗需要持续提供多学科疗法。由于新型冠状病毒病(COVID-19)大流行,我们中心与ALS患者的定期接触受到严重限制,支持性治疗的延迟使患者护理面临风险。我们基于D50疾病进展模型建立了一个分诊系统,从而能够识别出疾病侵袭性高(D50<30)的前瞻性队列。根据37例疾病侵袭性高的患者的疾病特定需求和能力,积极为他们提供电话或现场随访。在此,我们描述了2020年3月至6月COVID-19造成限制期间这些前瞻性努力的程序、障碍和结果。总之,4例疾病侵袭性高的患者开始接受无创通气,2例接受了胃造口术。我们可以证明,在COVID-19疫情爆发前一年的类似时间段内,回顾性队列中诱导了相当数量的高级护理。我们通过D50模型指标识别高危患者的工作流程可以很容易地在现有中心实施和整合。它有助于为我们的ALS患者维持高质量的高级护理计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/6e8c90cb165a/jcm-09-02873-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/51a2f81b0507/jcm-09-02873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/4111243a16b3/jcm-09-02873-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/ab837a8ed9c6/jcm-09-02873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/be9fad387189/jcm-09-02873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/6e8c90cb165a/jcm-09-02873-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/51a2f81b0507/jcm-09-02873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/4111243a16b3/jcm-09-02873-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/ab837a8ed9c6/jcm-09-02873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/be9fad387189/jcm-09-02873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55aa/7565659/6e8c90cb165a/jcm-09-02873-g005.jpg

相似文献

1
Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model.2019年冠状病毒病大流行期间肌萎缩侧索硬化症患者的分诊:D50模型的应用
J Clin Med. 2020 Sep 5;9(9):2873. doi: 10.3390/jcm9092873.
2
Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model.脑脊液神经丝轻链(NfL)可预测肌萎缩侧索硬化症的疾病侵袭性:D50疾病进展模型的应用
Front Neurosci. 2021 Apr 6;15:651651. doi: 10.3389/fnins.2021.651651. eCollection 2021.
3
Impact of SARS-CoV-2 infection and COVID-19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain.西班牙瓦伦西亚地区 2019 冠状病毒病大流行对肌萎缩侧索硬化症患者发病率和死亡率的影响。
Eur J Neurol. 2024 Dec;31(12):e16465. doi: 10.1111/ene.16465. Epub 2024 Sep 6.
4
Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan.日本肌萎缩侧索硬化症患者及其家属和护理人员对 COVID-19 大流行的矛盾反应。
Intern Med. 2021;60(10):1519-1524. doi: 10.2169/internalmedicine.6810-20. Epub 2021 May 15.
5
Accelerated Early Progression of Amyotrophic Lateral Sclerosis over the COVID-19 Pandemic.肌萎缩侧索硬化症在新冠疫情期间的加速早期进展
Brain Sci. 2021 Sep 29;11(10):1291. doi: 10.3390/brainsci11101291.
6
Ethical considerations in the management of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的治疗中的伦理问题。
Prog Neurobiol. 2013 Nov;110:45-53. doi: 10.1016/j.pneurobio.2013.05.001. Epub 2013 Jun 2.
7
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?当代肌萎缩侧索硬化症患者疾病进展较慢且生存期延长:肌萎缩侧索硬化症的自然史正在改变吗?
Arch Neurol. 2006 Aug;63(8):1139-43. doi: 10.1001/archneur.63.8.1139.
8
Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers.意大利肌萎缩侧索硬化症护理:一项在神经科中心开展的全国性研究。
J Neurol Sci. 2001 Oct 15;191(1-2):145-50. doi: 10.1016/s0022-510x(01)00622-0.
9
Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever.肌萎缩侧索硬化症(ALS):三个改变人们生活的字母。永远改变。
Arq Neuropsiquiatr. 2009 Sep;67(3A):750-82. doi: 10.1590/s0004-282x2009000400040.
10
Dental care and infection-control procedures during the COVID-19 pandemic: The experience in Taipei City Hospital, Taiwan.2019冠状病毒病大流行期间的牙科护理与感染控制程序:台湾台北市立联合医院的经验
J Dent Sci. 2020 Sep;15(3):369-372. doi: 10.1016/j.jds.2020.05.011. Epub 2020 May 29.

引用本文的文献

1
Phosphorylated neurofilament heavy chain (pNfH) concentration in cerebrospinal fluid predicts overall disease aggressiveness (D50) in amyotrophic lateral sclerosis.脑脊液中磷酸化神经丝重链(pNfH)浓度可预测肌萎缩侧索硬化症的整体疾病侵袭性(D50)。
Front Neurosci. 2025 Mar 12;19:1536818. doi: 10.3389/fnins.2025.1536818. eCollection 2025.
2
Impact of the COVID-19 pandemic on the mental and physical wellbeing of patients with motor neuron disease and other neuromuscular disease.新冠疫情对运动神经元病及其他神经肌肉疾病患者身心健康的影响
Front Neurol. 2025 Feb 19;16:1514983. doi: 10.3389/fneur.2025.1514983. eCollection 2025.
3

本文引用的文献

1
Spreading in ALS: The relative impact of upper and lower motor neuron involvement.ALS 中的扩散:上下运动神经元受累的相对影响。
Ann Clin Transl Neurol. 2020 Jul;7(7):1181-1192. doi: 10.1002/acn3.51098. Epub 2020 Jun 18.
2
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.2020 年,由于潜在健康状况,全球、区域和国家估计有多少人面临 COVID-19 重症风险增加:一项建模研究。
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017. doi: 10.1016/S2214-109X(20)30264-3. Epub 2020 Jun 15.
3
Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy.
T1-weighted MRI texture analysis in amyotrophic lateral sclerosis patients stratified by the D50 progression model.
根据D50进展模型分层的肌萎缩侧索硬化症患者的T1加权磁共振成像纹理分析
Brain Commun. 2024 Nov 5;6(6):fcae389. doi: 10.1093/braincomms/fcae389. eCollection 2024.
4
Amyotrophic Lateral Sclerosis: Advances and Prospects.肌萎缩侧索硬化症:进展与展望
J Clin Med. 2023 Aug 1;12(15):5055. doi: 10.3390/jcm12155055.
5
Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces.新兴技术在肌萎缩侧索硬化症患者管理中的应用:从远程医疗到辅助机器人和神经接口。
J Neurol. 2022 Jun;269(6):2910-2921. doi: 10.1007/s00415-022-10971-w. Epub 2022 Jan 21.
6
Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis.球部和肢体起病的肌萎缩侧索硬化症的灰质和白质变化模式不同。
Neuroimage Clin. 2021;30:102674. doi: 10.1016/j.nicl.2021.102674. Epub 2021 Apr 15.
在新冠疫情期间,远程医疗是为肌萎缩侧索硬化症患者提供护理的有用工具:来自意大利南部的结果。
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(7-8):542-548. doi: 10.1080/21678421.2020.1773502. Epub 2020 Jun 12.
4
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities.美国在 COVID-19 大流行期间的肌萎缩侧索硬化症护理和研究:挑战与机遇。
Muscle Nerve. 2020 Aug;62(2):182-186. doi: 10.1002/mus.26989. Epub 2020 Jun 5.
5
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19.新冠疫情时代用于肌萎缩侧索硬化症的远程医疗与技术设备
Neurol Sci. 2020 Jun;41(6):1365-1367. doi: 10.1007/s10072-020-04457-8. Epub 2020 May 21.
6
Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data.肌萎缩侧索硬化症疾病进程建模:来自横断面健康相关生活质量数据的伪纵向见解。
Health Qual Life Outcomes. 2020 May 1;18(1):117. doi: 10.1186/s12955-020-01372-6.
7
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.法国罕见神经肌肉疾病护理网络在 COVID-19 大流行期间对神经肌肉患者护理的指导意见。
Rev Neurol (Paris). 2020 Jun;176(6):507-515. doi: 10.1016/j.neurol.2020.04.004. Epub 2020 Apr 20.
8
Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme.肌萎缩侧索硬化症的症状性药物治疗:来自基于平台的药物管理计划的数据分析。
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):783-785. doi: 10.1136/jnnp-2020-322938. Epub 2020 Apr 21.
9
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis.人类新型冠状病毒感染(COVID-19):一项范围综述与荟萃分析
J Clin Med. 2020 Mar 30;9(4):941. doi: 10.3390/jcm9040941.
10
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.控制策略对减少社交接触以控制中国武汉 COVID-19 疫情的效果:建模研究。
Lancet Public Health. 2020 May;5(5):e261-e270. doi: 10.1016/S2468-2667(20)30073-6. Epub 2020 Mar 25.